Agency / Source: General Electric Company

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GE, Feinstein Institute Demonstrate Use of Ultrasound to Alter Inflammatory and Metabolic Response - GE Research and Feinstein Institute for Medical Research bioelectronic medicine teams have demonstrated potentially breakthrough non-invasive methods to regulate dysfunction in the body’s metabolic or inflammatory control systems using ultrasound - Feinst
GE, Feinstein Institute Demonstrate Use of Ultrasound to Alter Inflammatory and Metabolic Response

 

PRZOOM - /newswire/ - NISKAYUNA, NY, United States, 2019/03/12 - GE Research and Feinstein Institute for Medical Research bioelectronic medicine teams have demonstrated potentially breakthrough non-invasive methods to regulate dysfunction in the body’s metabolic or inflammatory control systems using ultrasound - Feinst. NYSE: GE

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Ultrasound used to non-invasively stimulate specific parts of the spleen and liver and activate the nervous system to regulate body’s inflammatory or metabolic response in preclinical studies;
• Key targets in the spleen shown to reduce inflammatory markers that are key drug targets in Arthritis, Irritable Bowel Disease (IBD) and other chronic inflammatory conditions;
• Key targets in the liver shown to regulate blood glucose, which could lead to non-invasive ways to treat diabetes and other metabolic diseases;
• Findings featured in Nature Communications article.

GE Research and Feinstein Institute for Medical Research bioelectronic medicine teams have demonstrated potentially breakthrough non-invasive methods to regulate dysfunction in the body’s metabolic or inflammatory control systems using ultrasound. The findings were reported in this week’s edition of Nature Communications. This article follows a medical first from The Feinstein Institute and GE Research to read what nerves are saying about inflammation in the body.

Bioelectronic medicine combines neuroscience, molecular biology and bioengineering to tap into the nervous system to treat disease and injury without the use of pharmaceuticals. Published bioelectronic medicine research has shown implanted devices stimulated nerves for therapeutic outcome. This most recent paper discusses the use of a non-invasive ultrasound technique to stimulate nerve features directly within target organs in a very precise manner.

“We have found that using ultrasound in very specific and targeted ways, we can reduce inflammatory markers and alter metabolism,” said Chris Puleo, a GE biomedical engineer and co-author of the Nature Communications article. “In our studies, we show that applying ultrasound to a specific target in the spleen altered inflammatory markers that can cause arthritis, IBD and other ailments. And when targeting a specific part of the liver, we were able to modulate blood glucose levels.”

“Major advances in understanding the immune system launched the new field of bioelectronic medicine, using devices targeting nerves to replace drugs. Non-invasive bioelectronic treatments have been limited until now,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute and co-author on the paper. “The potential for ultrasound devices to target specific reflex neural pathways to block inflammation represents a major contribution to the field.”

“What’s exciting is that we have demonstrated the use of ultrasound as a potential non-invasive alternative to current therapies that could lead to revolutionary new ways to treat various illnesses,” said Victoria Cotero, a GE biologist and co-author of the manuscript.

Looking forward, more preclinical studies will be required to understand the full potential and effects of these new stimulation methods using ultrasound. In addition, human trials will be needed to further develop and validate these methods for potential future medical applications.

About GE Research

GE Research (ge.com/research) is GE’s innovation powerhouse where research meets reality. We are a world-class team of 1,000+ scientific, engineering and marketing minds (600+ Ph. Ds), working at the intersection of physics and markets, physical and digital technologies, and across a broad set of industries to deliver world-changing innovations and capabilities for our customers.

About the Feinstein Institute

The Feinstein Institute for Medical Research (FeinsteinInstitute.org) is the research arm of Northwell Health (northwell.edu), the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the Feinstein Institute includes 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine a new field of science that has the potential to revolutionize medicine.

Contact: David Robbins
P: 516-465-8325 - E: drobbins2[.]northwell.edu.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: General Electric Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


GE, Feinstein Institute Demonstrate Use of Ultrasound to Alter Inflammatory and Metabolic Response

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Bioelectronic | GE Research
Contact: Todd Alhart - GE.com 
518-338-5880 todd.alhart[.]ge.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any General Electric Company securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From General Electric Company / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Artificial Intelligence, Tele-ophthalmology, and IoT to Drive the Ophthalmic Diagnostic and Monitoring Devices Market Finds Frost & Sullivan
Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T
KRAIBURG TPE and NEXTIS Partner on Flexible USB Socket Protection Cover Molded in THERMOLAST® for Respiratory Devices
Hyland Healthcare Receives Frost & Sullivan’s 2020 North America Product Leadership Award for Creating a New Standard in PACS Technology
VDL and DSM Form Joint Venture to Manufacture and Commercialize Medical Facemasks and PPE Filter Materials
Charge and Sanitize Mobile Devices with Tripp Lite’s New Hospital-Grade UV Charging Stations
Candelis Lauded by Frost & Sullivan for Accelerating Accurate Diagnosis with its Multi-Modal Breast Imaging Solution, Advanced Breast Imaging Enterpri
Cutting-Edge micro-CT Imaging Research Shines New Light on Mooted SARS-CoV-2 Treatments
Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications
Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  RightITnow, Inc.

Visit  BizJobs.com

Visit  Limelon Advertising, Co.







 
  ©2020 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today